covid novavax - Search News

Order byBest matchMost fresh

Novavax Soars

Healthy Returns: Novavax scores narrower Covid vaccine approval after delay

Novavax can finally breathe a sigh of relief – at least a small one. The Food and Drug Administration approved the company's Covid-19 vaccine after more than a month of delay b

· 2d · on MSN

Novavax Soars After Covid Vaccine Secures Full FDA Approval

Clinical Advisor · 2h

FDA Approves Novavax’s COVID-19 Vaccine Nuvaxovid

· 5h

WA vaccine scientists push back against FDA changes around COVID shots

Seattle vaccine experts were surprised and confused by the country’s apparent new direction around updated COVID-19 shots, which top officials at the Food and Drug Administration revealed Tuesday and ...

· 16h

FDA tightens requirements for COVID vaccine, adding trials for healthy adults

· 17h

F.D.A. Poised to Restrict Access to Covid Vaccines

· 1d

FDA sets new COVID booster guidelines for healthy adults under 65

Vaccine makers have argued that because COVID vaccines have been changed annually to match the circulating strain of the virus, new placebo-controlled trials could delay availability of the shots unt...

· 20h

FDA may limit future Covid-19 shots to older people and those at risk of serious infection

Las Vegas Sun · 1d

RFK Jr. pledged not to upend US vaccine system, but big changes are underway

4hon MSN

Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for new clinical trials

The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at higher risk of severe disease, but will require vaccine makers to conduct major new clinical trials before approving them for wider use.

12m

FDA may limit future COVID-19 boosters to seniors, those at higher risk for complications

US Food and Drug Administration officials are changing the agency's standards for updated COVID-19 booster shots with focus on seniors, high-risk persons.

FDA’s new approach raises questions about fall COVID vaccine availability

Health experts say there are legitimate questions about how much everyone still benefits from yearly COVID vaccination or whether they should be recommended only for people at increased risk.

17hon MSN

FDA sets new COVID booster guidelines for healthy adults under 65

The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.

50mon MSN

BofA Reiterates Hold Rating on Novavax (NVAX) Stock

The approval of Nuvaxovid for use in older and high-risk adults will generate around $175 million in milestone payments from Sanofi during Q3 and an additional $50 million in the second half of 2025.